Healthcare Trust of America, Inc. (NYSE:HTA) shares fell -1.29% in last trading session and ended the day at $26.72. HTA Gross Margin is 69.50% and its has a return on assets of 1.40%. Healthcare Trust of America, Inc. (NYSE:HTA) quarterly performance is 6.23%.
On 5 January, Healthcare Trust of America, Inc. (NYSE:HTA) announced that it has named Dan Klein to the newly created position of Executive Vice President of Business Development. Mr. Klein will report directly to the Company’s Chairman and CEO, Scott D. Peters. In this role, Dan will help drive HTA’s investment activities with a primary responsibility for growing HTA’s strategic relationships with health systems, academic medical centers, universities with a healthcare focus, physicians and regional developers.
Sprint Corporation (NYSE:S) ended the last trading day at $3.10. Company weekly volatility is calculated as 6.39% and price to cash ratio as 5.93. Sprint Corporation (NYSE:S) showed a weekly performance of -13.65%.
Sprint Corporation (NYSE:S) said that, it hunt for $2.5 billion in cost savings is rolling along, with managers checking on 1,739 cost-cutting initiatives each day, the company’s chief financial officer told investors Thursday.
On 13 January, Xcel Energy Inc. (NYSE:XEL) shares fell -0.61% and was closed at $36.11. XEL EPS growth in last 5 year was 6.40%. Xcel Energy Inc. (NYSE:XEL) year to date (YTD) performance is 0.56%.
Xcel Energy Inc. (NYSE:XEL) said that, it has awarded OriginClear Inc’s Progressive Water Treatment Inc (PWT) a contract valued at nearly US$2 million for a boiler feedwater treatment system.
Staples, Inc. (NASDAQ:SPLS) shares fell -1.48% in last trading session and ended the day at $9.30. SPLS Gross Margin is 26.20% and its has a return on assets of 0.30%. Staples, Inc. (NASDAQ:SPLS) quarterly performance is -21.70%.
On 12 January, Staples, Inc. (NASDAQ:SPLS) said that, freelance economy is growing rapidly, a trend with significant implications for the workplace. Nearly one in four employees freelance in some capacity, according to the Staples Advantage Workplace Index, a recent study of office workers in the U.S. conducted by the business-to-business division of .
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) caters to the Healthcare space. Its weekly performance is -28.29%. On the last day of trading company shares ended up at $7.20. Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) distance from 50-day simple moving average (SMA50) is -28.14%.
Leerink Swann reiterated their outperform rating on shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) in a research report released on Tuesday, MarketBeat reports. They currently have a $20.00 price target on the biopharmaceutical company’s stock, down from their previous price target of $24.00.
Leave a Reply